目的:观察阿法骨化醇治疗绝经后骨质疏松症的疗效。
AIM: To observe the clinical effects of alfacalcidol in the treatment of postmenopausal osteoporosis.
目的探索健骨冲剂对绝经后骨质疏松症疗效的作用机制。
To explore the therapeutic effect and mechanism of Jiangu granule (JGG) on postmenopausal osteoporosis.
目的研究不同剂量雌激素对绝经后骨质疏松症的治疗作用。
Purpose To study the effects of prevention and treatment in postmenopausal osteoporosis with different dose hormone replacement therapy.
结论仙灵强骨口服液对绝经后骨质疏松症模型大鼠有预防作用。
Conclusion XLQGKFY has a good preventive effect on postmenopausal osteoporosis which provides for clinical use.
本文就绝经后骨质疏松症及其治疗药物与牙周炎的关系做一综述。
This paper summarizes the relationship between periodontitis and post menopausal osteoporosis including the medicine therapy.
目的观察中药制剂金刚健骨片对绝经后骨质疏松症细胞因子的影响。
Objective to observe the effect of Jingang Jiangu tablet on cell factors in ovariectomized rats with osteoporosis.
目的观察小剂量雌孕激素联合使用防治绝经后骨质疏松症的临床疗效。
ObjectiveTo observe clinical therapeutic efficacy of combining administration with small doses of estrogen and progesterone in the treatment and prophylaxis of postmenopausal osteoporosis.
雌激素替代疗法和运动疗法在防治绝经后骨质疏松症中具有重要作用。
Estrogen replacement therapy and exercise therapy have important effects on preventing and treating postmenopausal osteoporosis.
目的:观察补肾健脾针法配合阿是穴治疗绝经后骨质疏松症的临床疗效。
Purpose:To observe about tonifying the kidney and the spleen acupuncture therapy on the patients with postmenopausal osteoporosis(PMOP).
目的:探讨利塞膦酸钠治疗绝经后骨质疏松症的临床疗效,并评价其安全性。
Objective:To evaluate the effect and safety of oral administration of residronate sodium in treatment of postmenopausal women with osteoporosis.
绝经后骨质疏松症治疗中优化双膦酸盐类药物使用剂量和频率:病人的考虑。
Optimizing dosing frequencies for bisphosphonates in the management of postmenopausal osteoporosis: patient considerations.
结论:生活质量指标可以作为绝经后骨质疏松症医疗后果评价的指标和依据之一。
Conclusion QOL may become one of the indexes of medical treatment outcome assessment system for PMOP.
目的:观察健骨方治疗绝经后骨质疏松症(pmop)的疗效,并探讨其作用机制。
Objective: To explore the effect of Jiangu recipe on the patients with postmenopausal osteoporosis (PMOP) and its mechanism.
摘要 :以维生素D类药物防治绝经后骨质疏松症的研究是近年来医学领域的一个热点。
Abstract: In recent years prevention and treatment of postmenopausal osteoporosis using vitamin D is a hot topic in the field of medicine.
目的观察渐进抗阻训练结合阿仑膦酸钠疗法对提高绝经后骨质疏松症患者腰椎骨密度的效果。
Objective To observe the effect of progressive resistance exercise combined with alendronate sodium on bone mineral density(BMD)of lumbar spine in patients with postmenopausal osteoporosis.
结论:阿法骨化醇治疗绝经后骨质疏松症具有改善症状、降低骨转换率、纠正骨量丢失的作用。
CONCLUSIONS: Alfacalcidol can alleviate symptoms, decrease bone turnover rate and redress loss of bone density in postmenopausal osteoporosis.
绝经后骨质疏松症是一个重要的公共健康问题,有关运动疗法与绝经后妇女骨骼的研究越来越多。
Postmenopausal osteoporosis is a major public health concern. Many studies have been done involving exercise therapy and effect on BMD of postmenopausal women.
他们的目的是简化医疗决策,并帮助医生和病人作出关于骨骼健康和绝经后骨质疏松症的正确决策。
They are intended to simplify medical decision making and to help physicians and their patients make good decisions about skeletal health and postmenopausal osteoporosis.
笔者就雌激素与运动防治绝经后骨质疏松症的可能作用机制及其联合作用效果的研究进展作一综述。
This review focuses on the potential mechanism and combined effect between estrogen replacement and exercise training so as to prevent and treat osteoporosis in postmenopausal women.
文章探讨了肾虚血瘀与绝经后骨质疏松症的关系,着重阐述了血瘀症型与绝经后骨质疏松症发病过程的关系。
The paper investigated the relationship between renal deficiency, blood stasis, and PMOP mainly expounded the relationship between types of blood stasis and the process filled PMOP.
目的:研究绝经后骨质疏松症与四肢骨折的关系,为防治绝经后四肢骨质疏松性骨折提供有用的数据和预防措施。
To provided useful data and measures for prevention and cure of postmenopausal extremity osteoporosis fracture, the relation between postmenopausal osteoporosis and extremity fracture was studied.
绝经后骨质疏松症是一种代谢性骨疾病,是绝经后妇女雌激素水平降低导致破骨细胞的骨吸收大于成骨细胞的骨形成作用。
Postmenopausal osteoporosis is a kind of metabolic osteopathy, whose cause is that bone absorption of osteoclast is more forceful than osteogenesis of osteoblast.
骨质疏松症随年龄增长出现加速性骨质丧失且在绝经后妇女中特别常见,使其有骨折的风险(如髋骨、腕骨、椎骨)。
Osteoporosis is accelerated bone loss with age and is particularly common amongst postmenopausal women, putting them at risk for fractures (hip, wrist, vertebrae).
雷洛昔芬还被用于防治绝经后妇女骨质疏松症。
Raloxifene is also used in prevention and treatment of osteoporosis in postmenopausal women.
极低的骨密度会导致一种叫做骨质疏松症的疾病。这种症状被公认为是女性绝经后出现的问题。
Very low bone density results in a disease called osteoporosis, which is most recognized as a problem in women after menopause.
雷洛昔芬是用来预防和治疗绝经后妇女的骨质疏松症的。
Raloxifene is indicated for the treatment and prevention of osteoporosis in postmenopausal women.
雷洛昔芬是用来预防和治疗绝经后妇女的骨质疏松症的。
Raloxifene is indicated for the treatment and prevention of osteoporosis in postmenopausal women.
应用推荐